Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.
Belkacemi Y, Latorzeff I, Hasbini A, Coraggio G, Pasquier D, Toledano A, Hennequin C, Bossi A, Chapet O, Crehange G, Guerif S, Duberge T, Allouache N, Clavere P, Gross E, Supiot S, Azria D, Bolla M, Sargos P. Belkacemi Y, et al. Among authors: chapet o. Cancer Radiother. 2020 Dec;24(8):892-897. doi: 10.1016/j.canrad.2020.03.014. Epub 2020 Nov 2. Cancer Radiother. 2020. PMID: 33144063 Review.
[Conformal radiotherapy of non-small-cell lung cancer].
Mornex F, Giraud P, Van Houtte P, Mirimanoff R, Chapet O, Loubeyre P. Mornex F, et al. Among authors: chapet o. Cancer Radiother. 1999 Sep-Oct;3(5):425-36. doi: 10.1016/s1278-3218(00)87980-9. Cancer Radiother. 1999. PMID: 10572512 Review. French.
[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials].
Beckendorf V, Bachaud JM, Bey P, Bourdin S, Carrie C, Chapet O, Cowen D, Guérif S, Hay HM, Lagrange JL, Maingon P, Le Prisé E, Pommier P, Simon JM. Beckendorf V, et al. Among authors: chapet o. Cancer Radiother. 2002 Nov;6 Suppl 1:78s-92s. doi: 10.1016/s1278-3218(02)00217-2. Cancer Radiother. 2002. PMID: 12587386 Review. French.
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.
Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P. Beckendorf V, et al. Among authors: chapet o. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65. doi: 10.1016/j.ijrobp.2004.05.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519775 Clinical Trial.
[Radiation-induced sequelae: toward an individual profile].
Azria D, Belkacemi Y, Lagrange JL, Chapet O, Mornex F, Maingon P, Hennequin C, Rosenstein B, Ozsahin M. Azria D, et al. Among authors: chapet o. Cancer Radiother. 2008 Nov;12(6-7):619-24. doi: 10.1016/j.canrad.2008.07.009. Epub 2008 Aug 30. Cancer Radiother. 2008. PMID: 18757226 French.
[Prostate cancer 2010. Therapeutic innovations].
Richaud P, Chapet O, Azria D, Soulié M, Salomon L, Hennequin C, Culine S. Richaud P, et al. Among authors: chapet o. Cancer Radiother. 2011 Mar;15(2 Suppl):7-11. doi: 10.1016/S1278-3218(11)70002-6. Cancer Radiother. 2011. PMID: 21513892 French.
[Image-guided radiotherapy in prostate cancer: concepts and implications].
Créhange G, Martin E, Supiot S, Chapet O, Mazoyer F, Naudy S, Maingon P. Créhange G, et al. Among authors: chapet o. Cancer Radiother. 2012 Sep;16(5-6):430-8. doi: 10.1016/j.canrad.2012.07.183. Epub 2012 Aug 23. Cancer Radiother. 2012. PMID: 22921961 French.
123 results